Works about SOFOSBUVIR

Results: 562
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Micro-elimination of hepatitis C in patients with chronic kidney disease: an Egyptian single-center study.

    Published in:
    Egyptian Journal of Internal Medicine, 2022, v. 34, n. 1, p. 1, doi. 10.1186/s43162-022-00139-3
    By:
    • George Michael, Tari;
    • Anwar, Christina A.;
    • Ahmed, Ossama A.;
    • Sarhan, Iman;
    • Elshazly, Yehia;
    • Shaker, Mohammed K.;
    • Eltabbakh, Mohammed;
    • Hashem, Walaa;
    • Tawfic, Safaa R.;
    • Kamel, Shimaa Y.;
    • Kandil, Doaa M.;
    • Naguib, Gina G.;
    • Khedr, Abdelrahman;
    • Ghanem, Eman A.;
    • Dabbous, Hany;
    • Doss, Wahid;
    • El-Sayed, Manal H.
    Publication type:
    Article
    13
    14
    15
    16
    17

    Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience.

    Published in:
    2017
    By:
    • Ueda, Yoshihide;
    • Ikegami, Toru;
    • Yoshizumi, Tomoharu;
    • Maehara, Yoshihiko;
    • Akamatsu, Nobuhisa;
    • Kokudo, Norihiro;
    • Soyama, Akihiko;
    • Eguchi, Susumu;
    • Shinoda, Masahiro;
    • Kitagawa, Yuko;
    • Goto, Ryoichi;
    • Taketomi, Akinobu;
    • Okajima, Hideaki;
    • Uemoto, Shinji
    Publication type:
    journal article
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis.

    Published in:
    PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0200568
    By:
    • Mangia, Alessandra;
    • Losappio, Ruggero;
    • Cenderello, Giovanni;
    • Potenza, Domenico;
    • Mazzola, Michele;
    • De Stefano, Giulio;
    • Terreni, Natalia;
    • Copetti, Massimiliano;
    • Minerva, Nicola;
    • Piazzola, Valeria;
    • Bacca, Donato;
    • Palmieri, Vincenzo;
    • Sogari, Fernando;
    • Santoro, Rosanna
    Publication type:
    Article
    27

    The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir.

    Published in:
    PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0198642
    By:
    • Mawatari, Seiichi;
    • Oda, Kohei;
    • Tabu, Kazuaki;
    • Ijuin, Sho;
    • Kumagai, Kotaro;
    • Fujisaki, Kunio;
    • Hashiguchi, Masafumi;
    • Inada, Yukiko;
    • Uto, Hirofumi;
    • Hiramine, Yasunari;
    • Kure, Takeshi;
    • Hori, Takeshi;
    • Taniyama, Oki;
    • Kasai, Ai;
    • Tamai, Tsutomu;
    • Moriuchi, Akihiro;
    • Ido, Akio
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes.

    Published in:
    Transplant International, 2017, v. 30, n. 12, p. 1253, doi. 10.1111/tri.13018
    By:
    • Carrai, Paola;
    • Morelli, Cristina;
    • Cordone, Gabriella;
    • Romano, Antonietta;
    • Tamé, Mariarosa;
    • Lionetti, Raffaella;
    • Pietrosi, Giada;
    • Lenci, Ilaria;
    • Piai, Guido;
    • Russo, Francesco Paolo;
    • Coppola, Carmine;
    • Melazzini, Mario;
    • Montilla, Simona;
    • Pani, Luca;
    • Petraglia, Sandra;
    • Russo, Pierluigi;
    • Trotta, Maria Paola;
    • Martini, Silvia;
    • Toniutto, Pierluigi;
    • Bandiera, Francesco
    Publication type:
    Article
    38
    39
    40
    41

    Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.

    Published in:
    Transplant International, 2017, v. 30, n. 2, p. 196, doi. 10.1111/tri.12896
    By:
    • O'Leary, Jacqueline G.;
    • Fontana, Robert J.;
    • Brown, Kimberly;
    • Burton, James R.;
    • Firpi-Morell, Roberto;
    • Muir, Andrew;
    • O'Brien, Christopher;
    • Rabinovitz, Mordechai;
    • Reddy, Rajender;
    • Ryan, Robert;
    • Shprecher, Adam;
    • Villadiego, Shirley;
    • Prabhakar, Avinash;
    • Brown, Robert S.
    Publication type:
    Article
    42
    43

    Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1285, doi. 10.1007/s00262-022-03334-x
    By:
    • Kajiwara, Yoshinori;
    • Tazawa, Hiroshi;
    • Yamada, Motohiko;
    • Kanaya, Nobuhiko;
    • Fushimi, Takuro;
    • Kikuchi, Satoru;
    • Kuroda, Shinji;
    • Ohara, Toshiaki;
    • Noma, Kazuhiro;
    • Yoshida, Ryuichi;
    • Umeda, Yuzo;
    • Urata, Yasuo;
    • Kagawa, Shunsuke;
    • Fujiwara, Toshiyoshi
    Publication type:
    Article
    44
    45

    Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study.

    Published in:
    2018
    By:
    • Cusato, Jessica;
    • Nicolò, Amedeo De;
    • Boglione, Lucio;
    • Favata, Fabio;
    • Ariaudo, Alessandra;
    • Pinna, Simone Mornese;
    • Carcieri, Chiara;
    • Guido, Federica;
    • Avataneo, Valeria;
    • Cariti, Giuseppe;
    • De Nicolò, Amedeo;
    • Mornese Pinna, Simone;
    • Di Perri, Giovanni;
    • D'Avolio, Antonio
    Publication type:
    journal article
    46
    47
    48
    49
    50